CVE-2012-4822

Description

Multiple unspecified vulnerabilities in the JRE component in IBM Java 7 SR2 and earlier, Java 6.0.1 SR3 and earlier, Java 6 SR11 and earlier, Java 5 SR14 and earlier, and Java 142 SR13 FP13 and earlier; as used in IBM Rational Host On-Demand, Rational Change, Tivoli Monitoring, Smart Analytics System 5600, Tivoli Remote Control 5.1.2, WebSphere Real Time, Lotus Notes & Domino, Tivoli Storage Productivity Center, and Service Deliver Manager; and other products from other vendors such as Red Hat, allow remote attackers to execute arbitrary code via vectors related to "insecure use [of] multiple methods in the java.lang.class class."

9.3
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 10.24% Top 10%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory ibm.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://rhn.redhat.com/errata/RHSA-2012-1466.html third party advisory vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21616616 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21616594 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21616617 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21621154 vendor advisory
http://seclists.org/bugtraq/2012/Sep/38 third party advisory mailing list
http://www-01.ibm.com/support/docview.wss?uid=swg21616652 vendor advisory
http://rhn.redhat.com/errata/RHSA-2013-1455.html third party advisory vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg1IV29665 vendor advisory
http://www.securityfocus.com/bid/55495 vdb entry third party advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/78766 vdb entry
http://www-01.ibm.com/support/docview.wss?uid=swg21631786 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21615800 vendor advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21616490 vendor advisory
http://secunia.com/advisories/51327 third party advisory
https://www-304.ibm.com/support/docview.wss?uid=swg21616546 vendor advisory
http://rhn.redhat.com/errata/RHSA-2012-1467.html third party advisory vendor advisory
http://rhn.redhat.com/errata/RHSA-2012-1465.html third party advisory vendor advisory
http://secunia.com/advisories/51328 third party advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21616708 vendor advisory
http://secunia.com/advisories/51634 third party advisory
http://www-01.ibm.com/support/docview.wss?uid=swg21615705 vendor advisory
http://rhn.redhat.com/errata/RHSA-2013-1456.html third party advisory vendor advisory
http://secunia.com/advisories/51393 third party advisory
http://secunia.com/advisories/51326 third party advisory

Frequently Asked Questions

What is the severity of CVE-2012-4822?
CVE-2012-4822 has been scored as a critical severity vulnerability.
How to fix CVE-2012-4822?
To fix CVE-2012-4822, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-4822 being actively exploited in the wild?
It is possible that CVE-2012-4822 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~10% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.